Select your country
Select a country to go to the website of the respective STADA sales company.
United Kingdom (4)
Contributions to Society
In view of the fact that STADA, with its generics and biosimilar portfolio, provides society with access to affordable medical care and thus reduces the cost pressure on the health care systems, the Company makes a fundamental social contribution. At the same time, with its Branded Products portfolio, STADA contributes not only to health care in general, but also to preventive health care.
Product portfolio and development
To meet its social responsibility and to secure its competitive position over the long term, STADA’s product portfolio is continuously expanded and optimized.
STADA’s business model is focused on supplying the global health-care market with a near-comprehensive portfolio, comprising products with patent-free active ingredients at competitive prices. In the Generics segment, STADA pursues the goal of launching a generic product in the respective market directly following the expiration of the original product’s patent protection. In the Branded Products segment, which also generally includes active ingredients that are no longer protected, the focus is on additional benefits for patients.
STADA has implemented a Group-wide “idea-to-market” process for the execution of this concept. As part of this process, a detailed evaluation of all product ideas for the Generics and Branded Products segments is carried out from a technical, regulatory and commercial standpoint and according to a global market analysis. All applicable quality requirements regarding the safety and efficacy of a product are reviewed during the development cycle and particularly in the context of the approval process. At the end of a product life cycle, relevant products are actively removed from the portfolio as part of an orderly process. The entire process is accompanied by the Executive Board. This ensures that the current portfolio composition follows the Group strategy as a whole. Continuous optimization of the product portfolio is monitored via the corresponding number of new product launches and the number of ongoing approval procedures (see “Fundamental Information about the Group – Group’s Business Model”).
STADA as a health partner
STADA believes that it is not only responsible for providing society with access to safe and affordable health care, but also further considers its role as a health-care partner. In this way, the Company also aims to increase society’s health competence and create awareness for dealing responsibly with one’s own health. In this context, the publication of high-quality health-care information has for many years made a contribution to the education of society. STADA has established a health blog (www.yourhealth.stada) and is present in the social networks. Both channels deal with a range of health topics with the aim of improving physical and mental well-being – in accordance with the self-image: “STADA: As a reliable partner, we take care of people’s health”.
In addition, the Group launched the STADA Health Report in 2014. The core of this report, which is supported by experts from the world of medicine, science, sport and lifestyle, is an annual study. Surveys carried out among the population on their attitudes, desires, behaviors and knowledge related to the topic of health form the basis of the respective studies. In 2018, the survey was conducted for the first time in various countries. In this context, 18,000 people in nine European countries were surveyed. The results of the survey conducted in 2018 appeared in the STADA Health Report for 2019 in various languages. The STADA Health Report 2020 is based on a study with over 24,000 participants from twelve European countries on “How Europe moves towards the future” – including a corona special with more than 6,000 respondents from six countries.